NCI Cervical Cancer ‘Last Mile’ Initiative (LMI)
Goal: Overcome barrier of lack of FDA approval for self-collection approaches for HPV testing-based cervical cancer screening
Approach: Engage public and private sector stakeholders to facilitate regulatory approvals for self-collection
Outcome: Increase screening access and reduce cervical cancer incidence in underserved and high-burden populations